CD8A and lung carcinoma: Two recent studies, including one from one of our groups, demonstrated that, in two independent cohorts of lung cancer patients, TRM cells were correlated with patient survival in both univariate and multivariate analysis, and this effect was independent of CD8+ T cells [38, 39].